Weave to Present at Raymond James 47th Annual Institutional Investors Conference

Why It Matters

The conference gives Weave direct exposure to institutional investors, underscoring its expanding role in AI‑enabled health‑tech and potentially accelerating capital inflows.

Key Takeaways

• Weave to present at Raymond James conference March 2, 2026
• CEO Brett White and CFO Jason Christiansen host fireside chat
• Live webcast available on investor relations site
• Serves ~40,000 small‑medium healthcare practices
• G2 2026 Best Software Award winner for healthcare

Pulse Analysis

The Raymond James Institutional Investors Conference is a premier venue where high‑growth public companies showcase strategy, financial outlook, and market positioning to a concentrated audience of fund managers and analysts. For a niche SaaS firm like Weave, participation signals confidence in its business model and offers a platform to articulate growth drivers, such as AI‑enhanced patient communication and payment automation, to investors seeking exposure to the booming health‑tech sector.

Weave’s platform integrates voice, text, and AI agents directly into practice workflows, automating scheduling, insurance verification, and payment collection. By embedding these capabilities into existing practice management systems, the company reduces administrative overhead and delivers real‑time analytics that help clinicians focus on care. With nearly 40,000 locations across the United States, Weave has demonstrated strong adoption among small and medium‑sized practices, a segment often overlooked by larger electronic health record vendors. The recent G2 Best Software award further validates its product quality and customer satisfaction.

From an investment perspective, the upcoming fireside chat provides a window into Weave’s revenue trajectory, margin expansion plans, and potential upsell opportunities within its existing customer base. Institutional investors will likely assess how AI advancements can accelerate billing efficiency and drive recurring revenue growth. As the healthcare industry continues to digitize, Weave’s niche focus positions it to capture market share, making its conference appearance a key catalyst for future valuation uplift.